Perrigo | PRGO - Ebitda


Perrigo reported $141.6M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Abbott USD 3.27B 178M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Merck USD 6.3B 2.09B Dec/2025
Nestle CHF 9.09B 594M Jun/2025
Pacira USD 40.24M 1.53M Mar/2026
Perrigo USD 141.6M 1.34B Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Reckitt Benckiser GBP 1.95B 708M Jun/2025
Sanofi EUR 3.31B 3.65B Mar/2026
Supernus Pharmaceuticals USD 29.23M 19.27M Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025
Zoetis USD 939M 101M Dec/2025